Published on 22/01/2026
This page provides a structured overview of DOSAGE FORMS, including key concepts and a curated list of related articles.
Overview
This topic covers essential principles, best practices, and real-world applications.
Key Topics & Articles
- Injectable Quality Failures Like Particulates? Sterile Manufacturing Solutions That Work
- Cream Separation and Ointment Grittiness? Root Causes and Fixes for Topicals
- Inhaler Dose Delivery Problems? Device-Formulation Solutions for Consistent Performance
- Suppository Melting and Leakage Issues? Formulation and Packaging Solutions
- Dental Product Performance Problems? Fixes for Consistency, Stability, and Release
- Emulsion Inversion after excipient change: mixing and sampling controls for QA review
- Texture Variability in ointment filling: mixing and sampling controls for QA review
- Color Change in cream manufacturing: GMP investigation and CAPA strategy
- Bioburden Spike Pre-Filtration during hold-time study: CAPA package with evidence and effectiveness checks
- Air Entrapment during inspection preparation: GMP investigation and CAPA strategy
- Sterility Test Failure during aseptic filling: data integrity checks for lab and shop floor
- Unplanned Line Stoppage post-sterile filtration: facility, people, process root cause mapping
- Aseptic Gowning Deviation during terminal sterilization: risk assessment for patient safety and recall
- Air Entrapment in cream manufacturing: packaging compatibility and stability justification
- Filter Integrity Failure during routine EM trending: how to classify deviation and set disposition
- Particulate
Matter Oos during routine EM trending: FDA/MHRA investigation narrative and batch impact
Bioburden Spike Pre-Filtration during routine EM trending: facility, people, process root cause mapping
Texture Variability after excipient change: GMP investigation and CAPA strategy
Em Excursion In Grade A during PAI readiness: facility, people, process root cause mapping
Odor Change during method transfer: mixing and sampling controls for QA review
Aseptic Gowning Deviation after maintenance intervention: risk assessment for patient safety and recall
Unplanned Line Stoppage during hold-time study: risk assessment for patient safety and recall
Emulsion Inversion during inspection preparation: how to document deviations for FDA/EMA
Bioburden Spike Pre-Filtration during terminal sterilization: facility, people, process root cause mapping
Endotoxin Oos during hold-time study: facility, people, process root cause mapping
Tube Leakage Complaint at accelerated stability: complaint trending and risk-based actions
Sterility Test Failure during power interruption: CAPA package with evidence and effectiveness checks
Ph Drift during homogenization: packaging compatibility and stability justification
High Visual Inspection Reject Rate during aseptic filling: CAPA package with evidence and effectiveness checks
Endotoxin Oos during terminal sterilization: risk assessment for patient safety and recall
How to Use This Hub
Use the list above to explore articles in a logical sequence. Start with fundamentals and then move into detailed, practical posts.